Go to the Global Legal Chronicle article
Go to the Law360 Pulse article
Go to The AmLaw Litigation Daily article
- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News & Insights
In the News
July 31, 2025 - Source: Global Legal Chronicle, Law360 Pulse and The AmLaw Litigation Daily
Dara Kurlancheek, Joe Eng, Mark Zambarda, Amanda Klingler, Lisa Horvath, Eric Valuyev and David Farber secure a complete defense verdict on behalf of CG Oncology in a dispute with ANI Pharmaceuticals over future royalties on net sales of cretostimogene or, in the alternative, $2.3B in unjust enrichment damages. The team is recognized in this week’s Law.com Litigator of the Week Runner’s Up and Shout Outs for securing this win on behalf of CG Oncology.
Featured Lawyers
Dara M. Kurlancheek
Washington, D.C.
Joseph D. Eng, Jr.
New York
Mark Zambarda
Denver
Amanda J. Klingler
Washington, D.C.
Lisa Ann Horvath
Austin
Eric Valuyev
Denver
Close
Featured Lawyers
Dara M. Kurlancheek
Washington, D.C.
Joseph D. Eng, Jr.
New York
Mark Zambarda
Denver
Amanda J. Klingler
Washington, D.C.
Lisa Ann Horvath
Austin
Eric Valuyev
Denver
David J. Farber
Washington, D.C.